Lancet report links doomscrolling to gambling and pornography
A new psychiatric commission estimates that 10% of people suffer from digital process addictions, a category that now includes social media scrolling.
By Nadia Khalil ·

A new report from the Lancet Psychiatry Commission estimates that 10% of the population is affected by digital process addictions. The commission groups excessive social media scrolling with gambling, gaming, and pornography under a single public health concern.
Doomscrolling is the act of spending hours mindlessly scrolling through social media feeds. While many people view this as a harmless pastime, the commission concluded that it warrants clinical attention. The group assembled for the report included top experts in the field of addiction medicine.
Professor Colin O’Gara, an addiction psychiatrist, discussed the findings on Newstalk Breakfast. He noted that the report lists social media, cyberbullying, digital hoarding, and cyberchondria alongside traditional behavioral addictions. Cyberchondria refers to the habit of looking up medical issues online to the point of distress. O’Gara described the 10% prevalence rate as very high.
These process addictions do not involve the use of a substance, which often makes them harder for individuals to identify. O’Gara explained that such conditions are typically hidden from view. He pointed to the release of the video game GTA 6 as a factor that may drive more gaming addiction. He estimated that 5% to 10% of players experience significant issues with gaming.
The report also highlights the impact of online pornography and the risks associated with AI chatbots. O’Gara stated that the field of medicine is moving quickly regarding these digital tools. He said clinicians need to be prepared for the clinical implications of AI, though the exact outcome remains to be seen.
O’Gara compared the current situation to the introduction of a gambling regulator. He noted that responding to new behavioral issues takes a great deal of time. He believes it is good that the conversation is happening now, but he emphasized the need to determine specific regulatory steps.
The state and medical professionals will now examine ways to ameliorate the situation. O’Gara said he does not know exactly how the AI piece will play out clinically, but he believes the industry is moving in the right direction by addressing these concerns.






